Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zicheng Pang

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Drug Design, Development and Therapy|May 5, 2025
Bibliometric Analysis of Non-Vitamin K Antagonist Oral Anticoagulants (NOACS) in the Prevention of Venous Thrombosis and Pulmonary EmbolismFangyi Zhou, Zicheng Pang, Zhuoming Chen, et al.
Molecular Cancer|August 1, 2024
Super-enhancer omics in stem cellHongying Ma, Jian Qu, Zicheng Pang, et al.
Archives of Toxicology|June 16, 2024
Development and validation of an automatic machine learning model to predict abnormal increase of transaminase in valproic acid-treated epilepsyHongying Ma, Sihui Huang, Fengxin Li, et al.
Experimental Cell Research|December 17, 2023
Equilibrative nucleotide transporter ENT3 (SLC29A3): A unique transporter for inherited disorders and cancersHongying Ma, Jian Qu, Yongkang Liao, et al.
Current Neuropharmacology|May 21, 2026
Bibliometric Analysis of White Matter Disease and Novel Drug TherapyJunfei Yi, Zicheng Pang, Yuerong Wu, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Drug Design, Development and Therapy|May 5, 2025
Bibliometric Analysis of Non-Vitamin K Antagonist Oral Anticoagulants (NOACS) in the Prevention of Venous Thrombosis and Pulmonary EmbolismFangyi Zhou, Zicheng Pang, Zhuoming Chen, et al.
Molecular Cancer|August 1, 2024
Super-enhancer omics in stem cellHongying Ma, Jian Qu, Zicheng Pang, et al.
Archives of Toxicology|June 16, 2024
Development and validation of an automatic machine learning model to predict abnormal increase of transaminase in valproic acid-treated epilepsyHongying Ma, Sihui Huang, Fengxin Li, et al.
Experimental Cell Research|December 17, 2023
Equilibrative nucleotide transporter ENT3 (SLC29A3): A unique transporter for inherited disorders and cancersHongying Ma, Jian Qu, Yongkang Liao, et al.
Current Neuropharmacology|May 21, 2026
Bibliometric Analysis of White Matter Disease and Novel Drug TherapyJunfei Yi, Zicheng Pang, Yuerong Wu, et al.
Pageof 1